Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne C Moorman

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Public Health Reports (Washington, D.C. : 1974)|July 22, 2023
Hepatitis C Virus-HIV Coinfection in the United States Among People Who Inject Drugs: Data Needed for Ending Dual EpidemicsAnne C Moorman, Danae Bixler, Eyasu H Teshale, et al.
Public Health Reports (Washington, D.C. : 1974)|July 26, 2024
Regional Differences in Hepatitis C-Related Hospitalization Rates, United States, 2012-2019Megan G Hofmeister, Yuna Zhong, Anne C Moorman, et al.
AIDS Patient Care and Stds|January 22, 2005
Factors related to and consequences of adherence to antiretroviral therapy in an ambulatory HIV-infected patient cohortMaria Deloria-Knoll, Joan S Chmiel, Anne C Moorman, et al.
Journal of the American Dental Association (1939)|May 29, 2016
Transmission of blood-borne pathogens in US dental health care settings: 2016 updateJennifer L Cleveland, Shellie Kolavic Gray, Jennifer A Harte, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|June 21, 2007
Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient StudyBenjamin Young, Kate Buchacz, Rose K Baker, et al.
AIDS Patient Care and Stds|April 21, 2006
Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected personsBenjamin Young, Paul J Weidle, Rose K Baker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 10, 2009
Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007Philip R Spradling, James T Richardson, Kate Buchacz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 14, 2014
Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010Reena Mahajan, Jian Xing, Stephen J Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2003
Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patientsKenneth A Lichtenstein, Kathleen M Delaney, Carl Armon, et al.
AIDS (London, England)|June 27, 2008
Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005Kate Buchacz, Rose K Baker, Anne C Moorman, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Public Health Reports (Washington, D.C. : 1974)|July 22, 2023
Hepatitis C Virus-HIV Coinfection in the United States Among People Who Inject Drugs: Data Needed for Ending Dual EpidemicsAnne C Moorman, Danae Bixler, Eyasu H Teshale, et al.
Public Health Reports (Washington, D.C. : 1974)|July 26, 2024
Regional Differences in Hepatitis C-Related Hospitalization Rates, United States, 2012-2019Megan G Hofmeister, Yuna Zhong, Anne C Moorman, et al.
AIDS Patient Care and Stds|January 22, 2005
Factors related to and consequences of adherence to antiretroviral therapy in an ambulatory HIV-infected patient cohortMaria Deloria-Knoll, Joan S Chmiel, Anne C Moorman, et al.
Journal of the American Dental Association (1939)|May 29, 2016
Transmission of blood-borne pathogens in US dental health care settings: 2016 updateJennifer L Cleveland, Shellie Kolavic Gray, Jennifer A Harte, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|June 21, 2007
Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient StudyBenjamin Young, Kate Buchacz, Rose K Baker, et al.
AIDS Patient Care and Stds|April 21, 2006
Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected personsBenjamin Young, Paul J Weidle, Rose K Baker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 10, 2009
Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007Philip R Spradling, James T Richardson, Kate Buchacz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 14, 2014
Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010Reena Mahajan, Jian Xing, Stephen J Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2003
Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patientsKenneth A Lichtenstein, Kathleen M Delaney, Carl Armon, et al.
AIDS (London, England)|June 27, 2008
Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005Kate Buchacz, Rose K Baker, Anne C Moorman, et al.
Pageof 9